EGFR and non-small cell lung carcinoma: Thus, this study was conducted to identify the relevant PRO‐CTCAE items for patients with NSCLC with EGFR Exon 20ins that would be relevant for future studies and describes the process undertaken for identifying and validating the relevant concepts.